Association between changes in genital immune markers and vaginal microbiome transitions in bacterial vaginosis

Abstract Bacterial vaginosis (BV), characterized by an imbalance in the vaginal microbiota, is a prevalent condition among women of reproductive age and a risk factor for human immunodeficiency virus, sexually transmitted infections, and preterm birth. BV is generally considered to induce mucosal in...

Full description

Saved in:
Bibliographic Details
Main Authors: Philipp Foessleitner, Briah Cooley Demidkina, Wafae El-Arar, Miles Goldenberg, Meena Murthy, Agnes Bergerat, Ofri Bar, Douglas S. Kwon, Caroline M. Mitchell
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-88208-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571839115689984
author Philipp Foessleitner
Briah Cooley Demidkina
Wafae El-Arar
Miles Goldenberg
Meena Murthy
Agnes Bergerat
Ofri Bar
Douglas S. Kwon
Caroline M. Mitchell
author_facet Philipp Foessleitner
Briah Cooley Demidkina
Wafae El-Arar
Miles Goldenberg
Meena Murthy
Agnes Bergerat
Ofri Bar
Douglas S. Kwon
Caroline M. Mitchell
author_sort Philipp Foessleitner
collection DOAJ
description Abstract Bacterial vaginosis (BV), characterized by an imbalance in the vaginal microbiota, is a prevalent condition among women of reproductive age and a risk factor for human immunodeficiency virus, sexually transmitted infections, and preterm birth. BV is generally considered to induce mucosal inflammation, but the specific pathways and cell types involved are not well characterized. This prospective study aimed to assess associations between microbial changes and mucosal immune responses in BV patients. Therefore, samples from 20 premenopausal women with BV and treated with metronidazole were analyzed. Vaginal swabs, menstrual cup, and endocervical cytobrush samples were collected before treatment, weekly for four weeks, and at 2, 4, and 6 months for Nugent scoring, immune cell populations and cytokine analysis. Of 105 study intervals, 27 (25.7%) showed improvement in Nugent category, 61 (58.1%) remained unchanged, and 17 (16.2%) worsened. Improvement correlated with decreased monocytes (p = 0.005), while worsening was linked to increased monocytes (p < 0.001) and dendritic cells (p = 0.02). B cells (p = 0.02) and IFN-γ-induced chemokines - IP-10 (p = 0.007), MIG (p = 0.049), and ITAC (p = 0.005) - were associated with improvement. In conclusion, although the T-cell-associated chemokines IP-10, ITAC, and MIG were strongly associated with improvements in Nugent category, our findings indicate that antigen-presenting cells, particularly monocytes, show the most dynamic response to shifts in the vaginal microbiota in patients with BV.
format Article
id doaj-art-14ca66fa8d134360b9713f8528f71abb
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-14ca66fa8d134360b9713f8528f71abb2025-02-02T12:16:01ZengNature PortfolioScientific Reports2045-23222025-01-0115111110.1038/s41598-025-88208-9Association between changes in genital immune markers and vaginal microbiome transitions in bacterial vaginosisPhilipp Foessleitner0Briah Cooley Demidkina1Wafae El-Arar2Miles Goldenberg3Meena Murthy4Agnes Bergerat5Ofri Bar6Douglas S. Kwon7Caroline M. Mitchell8Vincent Center for Reproductive Biology, Massachusetts General HospitalVincent Center for Reproductive Biology, Massachusetts General HospitalVincent Center for Reproductive Biology, Massachusetts General HospitalVincent Center for Reproductive Biology, Massachusetts General HospitalVincent Center for Reproductive Biology, Massachusetts General HospitalVincent Center for Reproductive Biology, Massachusetts General HospitalVincent Center for Reproductive Biology, Massachusetts General HospitalHarvard Medical SchoolVincent Center for Reproductive Biology, Massachusetts General HospitalAbstract Bacterial vaginosis (BV), characterized by an imbalance in the vaginal microbiota, is a prevalent condition among women of reproductive age and a risk factor for human immunodeficiency virus, sexually transmitted infections, and preterm birth. BV is generally considered to induce mucosal inflammation, but the specific pathways and cell types involved are not well characterized. This prospective study aimed to assess associations between microbial changes and mucosal immune responses in BV patients. Therefore, samples from 20 premenopausal women with BV and treated with metronidazole were analyzed. Vaginal swabs, menstrual cup, and endocervical cytobrush samples were collected before treatment, weekly for four weeks, and at 2, 4, and 6 months for Nugent scoring, immune cell populations and cytokine analysis. Of 105 study intervals, 27 (25.7%) showed improvement in Nugent category, 61 (58.1%) remained unchanged, and 17 (16.2%) worsened. Improvement correlated with decreased monocytes (p = 0.005), while worsening was linked to increased monocytes (p < 0.001) and dendritic cells (p = 0.02). B cells (p = 0.02) and IFN-γ-induced chemokines - IP-10 (p = 0.007), MIG (p = 0.049), and ITAC (p = 0.005) - were associated with improvement. In conclusion, although the T-cell-associated chemokines IP-10, ITAC, and MIG were strongly associated with improvements in Nugent category, our findings indicate that antigen-presenting cells, particularly monocytes, show the most dynamic response to shifts in the vaginal microbiota in patients with BV.https://doi.org/10.1038/s41598-025-88208-9Bacterial vaginosisVaginal mucosal cytokinesVaginal mucosal immune cellsMonocytesIP-10MIG
spellingShingle Philipp Foessleitner
Briah Cooley Demidkina
Wafae El-Arar
Miles Goldenberg
Meena Murthy
Agnes Bergerat
Ofri Bar
Douglas S. Kwon
Caroline M. Mitchell
Association between changes in genital immune markers and vaginal microbiome transitions in bacterial vaginosis
Scientific Reports
Bacterial vaginosis
Vaginal mucosal cytokines
Vaginal mucosal immune cells
Monocytes
IP-10
MIG
title Association between changes in genital immune markers and vaginal microbiome transitions in bacterial vaginosis
title_full Association between changes in genital immune markers and vaginal microbiome transitions in bacterial vaginosis
title_fullStr Association between changes in genital immune markers and vaginal microbiome transitions in bacterial vaginosis
title_full_unstemmed Association between changes in genital immune markers and vaginal microbiome transitions in bacterial vaginosis
title_short Association between changes in genital immune markers and vaginal microbiome transitions in bacterial vaginosis
title_sort association between changes in genital immune markers and vaginal microbiome transitions in bacterial vaginosis
topic Bacterial vaginosis
Vaginal mucosal cytokines
Vaginal mucosal immune cells
Monocytes
IP-10
MIG
url https://doi.org/10.1038/s41598-025-88208-9
work_keys_str_mv AT philippfoessleitner associationbetweenchangesingenitalimmunemarkersandvaginalmicrobiometransitionsinbacterialvaginosis
AT briahcooleydemidkina associationbetweenchangesingenitalimmunemarkersandvaginalmicrobiometransitionsinbacterialvaginosis
AT wafaeelarar associationbetweenchangesingenitalimmunemarkersandvaginalmicrobiometransitionsinbacterialvaginosis
AT milesgoldenberg associationbetweenchangesingenitalimmunemarkersandvaginalmicrobiometransitionsinbacterialvaginosis
AT meenamurthy associationbetweenchangesingenitalimmunemarkersandvaginalmicrobiometransitionsinbacterialvaginosis
AT agnesbergerat associationbetweenchangesingenitalimmunemarkersandvaginalmicrobiometransitionsinbacterialvaginosis
AT ofribar associationbetweenchangesingenitalimmunemarkersandvaginalmicrobiometransitionsinbacterialvaginosis
AT douglasskwon associationbetweenchangesingenitalimmunemarkersandvaginalmicrobiometransitionsinbacterialvaginosis
AT carolinemmitchell associationbetweenchangesingenitalimmunemarkersandvaginalmicrobiometransitionsinbacterialvaginosis